Literature DB >> 10864676

The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

E R Flores1, B L Allen-Hoffmann, D Lee, P F Lambert.   

Abstract

The production of the human papillomavirus type 16 (HPV-16) is intimately tied to the differentiation of the host epithelium that it infects. Infection occurs in the basal layer of the epithelium at a site of wounding, where the virus utilizes the host DNA replication machinery to establish itself as a low-copy-number episome. The productive stage of the HPV-16 life cycle occurs in the postmitotic suprabasal layers of the epithelium, where the virus amplifies its DNA to high copy number, synthesizes the capsid proteins (L1 and L2), encapsidates the HPV-16 genome, and releases virion particles as the upper layer of the epithelium is shed. Papillomaviruses are hypothesized to possess a mechanism to overcome the block in DNA synthesis that occurs in the differentiated epithelial cells, and the HPV-16 E7 oncoprotein has been suggested to play a role in this process. To determine whether E7 plays a role in the HPV-16 life cycle, an E7-deficient HPV-16 genome was created by inserting a translational termination linker (TTL) in the E7 gene of the full HPV-16 genome. This DNA was transfected into an immortalized human foreskin keratinocyte cell line shown previously to support the HPV-16 life cycle, and stable cell lines were obtained that harbored the E7-deficient HPV-16 genome episomally, the state of the genome found in normal infections. By culturing these cells under conditions which promote the differentiation of epithelial cells, we found E7 to be necessary for the productive stage of the HPV-16 life cycle. HPV-16 lacking E7 failed to amplify its DNA and expressed reduced amounts of the capsid protein L1, which is required for virus production. E7 appears to create a favorable environment for HPV-16 DNA synthesis by perturbing the keratinocyte differentiation program and inducing the host DNA replication machinery. These data demonstrate that E7 plays an essential role in the papillomavirus life cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864676      PMCID: PMC112172          DOI: 10.1128/jvi.74.14.6622-6631.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle.

Authors:  E R Flores; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  MDM-2 protein is expressed in different layers of normal human skin.

Authors:  J E Dazard; D Augias; H Neel; V Mils; V Marechal; N Basset-Séguin; J Piette
Journal:  Oncogene       Date:  1997-03-06       Impact factor: 9.867

3.  Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10.

Authors:  M N Ruesch; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells.

Authors:  G Teoh; M Urashima; A Ogata; D Chauhan; J A DeCaprio; S P Treon; R L Schlossman; K C Anderson
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

5.  The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals.

Authors:  S Song; H C Pitot; P F Lambert
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF).

Authors:  S E Seavey; M Holubar; L J Saucedo; M E Perry
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.

Authors:  J T Thomas; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

Authors:  D L Jones; R M Alani; K Münger
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

9.  Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.

Authors:  J T Thomas; W G Hubert; M N Ruesch; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

10.  Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

Authors:  K Lundgren; R Montes de Oca Luna; Y B McNeill; E P Emerick; B Spencer; C R Barfield; G Lozano; M P Rosenberg; C A Finlay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

View more
  95 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  A role for HPV16 E5 in cervical carcinogenesis.

Authors:  John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

4.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Human papillomaviruses: a growing field.

Authors:  Denise A Galloway
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 6.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

7.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.

Authors:  Enoc M Cortés-Malagón; José Bonilla-Delgado; José Díaz-Chávez; Alfredo Hidalgo-Miranda; Sandra Romero-Cordoba; Aykut Uren; Haydar Celik; Matthew McCormick; José A Munguía-Moreno; Eloisa Ibarra-Sierra; Jaime Escobar-Herrera; Paul F Lambert; Daniel Mendoza-Villanueva; Rosa M Bermudez-Cruz; Patricio Gariglio
Journal:  Virology       Date:  2013-09-27       Impact factor: 3.616

9.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.

Authors:  Kwang-Jin Oh; Anna Kalinina; Srilata Bagchi
Journal:  Virology       Date:  2009-11-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.